By Robin Foster HealthDay Reporter WEDNESDAY, April 17, 2024 (HealthDay Information) Zepbound, one of many wildly well-liked weight-loss medication that tens of millions of People now take, eased sleep apnea in overweight adults in two firm trials, drug maker Eli Lilly introduced Wednesday. First authorised to deal with weight problems by the U.S. Meals and...
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
You may also like
Contact Information
- Do not hesitate to contact us if you have questions about the subscription or your ads publish. We are here to help!
- E-mail at [email protected]
- Give us a call at our toll-free number: ((888) 503-2390